Management of Abnormal Uterine Bleeding

NACompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 30, 2024

Conditions

Abnormal Uterine Bleeding

Interventions

DRUG

Mefenamic acid 500 mg

To compare the effectiveness of mefenamic acid versus tranexamic acid in the management of abnormal uterine bleeding.

Trial Locations (1)

Ain Shams University Hospitals, Cairo

All Listed Sponsors

lead

Egymedicalpedia

INDUSTRY

NCT06369012 - Management of Abnormal Uterine Bleeding | Biotech Hunter | Biotech Hunter